Am Fam Physician. 2005 Oct 1;72(7):1285-8.

Milk thistle.

Source

Albert Einstein College of Medicine of Yeshiva University, Bronx, New York.

Abstract

Milk thistle has been used as a cytoprotectant for the treatment of liver disease, for the treatment and prevention of cancer, and as a supportive treatment of Amanita phalloides poisoning. Clinical studies are largely heterogeneous and contradictory. Aside from mild gastrointestinal distress and allergic reactions, side effects are rare, and serious toxicity rarely has been reported. In an oral form standardized to contain 70 to 80 percent silymarin, milk thistle appears to be safe for up to 41 months of use. Significant drug reactions have not been reported. Clinical studies in oncology and infectious disease that are under way will help determine the efficacy and effectiveness of milk thistle.

PMID:: 16225032; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Milk thistle and chronic liver disease. [Hepatology. 2005]
Milk thistle and chronic liver disease.
Hoofnagle JH. Hepatology. 2005 Jul; 42(1):4.
Review Milk thistle in liver diseases: past, present, future. [Phytother Res. 2010]
Review Milk thistle in liver diseases: past, present, future.
Abenavoli L, Capasso R, Milic N, Capasso F. Phytother Res. 2010 Oct; 24(10):1423-32.
Review Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. [Indian J Med Res. 2006]
Review Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
Pradhan SC, Girish C. Indian J Med Res. 2006 Nov; 124(5):491-504.
Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. [Ren Fail. 2010]
Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats.
Vessal G, Akmali M, Najafi P, Moein MR, Sagheb MM. Ren Fail. 2010 Jul; 32(6):733-9.
Review Milk thistle and the treatment of hepatitis. [Gastroenterol Nurs. 2001]
Review Milk thistle and the treatment of hepatitis.
Giese LA. Gastroenterol Nurs. 2001 Mar-Apr; 24(2):95-7.

See reviews... See all...

Cited by 2 PubMed Central articles

Multiple effects of silymarin on the hepatitis C virus lifecycle. [Hepatology. 2010]
Multiple effects of silymarin on the hepatitis C virus lifecycle.
Wagoner J, Negash A, Kane OJ, Martinez LE, Nahmias Y, Bourne N, Owen DM, Grove J, Brimacombe C, McKeating JA, et al. Hepatology. 2010 Jun; 51(6):1912-21.
Identification of hepatoprotective flavonolignans from silymarin. [Proc Natl Acad Sci U S A. 2010]
Identification of hepatoprotective flavonolignans from silymarin.
Polyak SJ, Morishima C, Lohmann V, Pal S, Lee DY, Liu Y, Graf TN, Oberlies NH. Proc Natl Acad Sci U S A. 2010 Mar 30; 107(13):5995-9. Epub 2010 Mar 15.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Milk thistle.
Milk thistle.
Am Fam Physician. 2005 Oct 1 ;72(7):1285-8.

PubMed
Milk thistle: effects on liver disease and cirrhosis and clinical adverse effect...
Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects.
Evid Rep Technol Assess (Summ). 2000 ;(21):1-3.

PubMed
Treatment of 153 Japanese patients with Q-switched alexandrite laser.
Treatment of 153 Japanese patients with Q-switched alexandrite laser.
Lasers Med Sci. 2007 Sep ;22(3):159-63. Epub 2007 Jan 16 .

PubMed
Mongolian spots with involvement of mandibular area.
Mongolian spots with involvement of mandibular area.
J Dermatol. 2007 Jun ;34(6):381-4.

PubMed
A novel PAX3 rearrangement in embryonal rhabdomyosarcoma.
A novel PAX3 rearrangement in embryonal rhabdomyosarcoma.
Cancer Genet Cytogenet. 2009 Mar ;189(2):98-104.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: